|
TLK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36799999608905E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08840000001553E-06 |
| Normal-vs-Stage2 |
1.227680E-04 |
| Normal-vs-Stage3 |
3.74960000049107E-07 |
| Normal-vs-Stage4 |
1.65610000002481E-06 |
| Stage1-vs-Stage2 |
5.391000E-01 |
| Stage1-vs-Stage3 |
2.136200E-01 |
| Stage1-vs-Stage4 |
1.589810E-01 |
| Stage2-vs-Stage3 |
7.835000E-01 |
| Stage2-vs-Stage4 |
5.369800E-01 |
| Stage3-vs-Stage4 |
6.697000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.48900000107588E-08 |
| Normal-vs-AfricanAmerican |
2.520200E-02 |
| Normal-vs-Asian |
7.99980000000255E-05 |
| Caucasian-vs-AfricanAmerican |
2.279400E-01 |
| Caucasian-vs-Asian |
7.555200E-01 |
| AfricanAmerican-vs-Asian |
3.594600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09100000000861E-06 |
| Normal-vs-Female |
6.94859999539332E-08 |
| Male-vs-Female |
9.184400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8881699999973E-05 |
| Normal-vs-Age(41-60Yrs) |
2.80209999647951E-08 |
| Normal-vs-Age(61-80Yrs) |
1.77227000000002E-05 |
| Normal-vs-Age(81-100Yrs) |
1.513690E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.410200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.665400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.378800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.735800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.786200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.400000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.969400E-01 |
| Classical-VS-Follicular |
4.009000E-01 |
| Classical-VS-Other |
7.558400E-01 |
| Classical-VS-Normal |
4.45089999999704E-05 |
| Tall-VS-Follicular |
9.385400E-01 |
| Tall-VS-Other |
9.737800E-01 |
| Tall-VS-Normal |
1.081910E-03 |
| Follicular-VS-Other |
9.905000E-01 |
| Follicular-VS-Normal |
4.02700000000644E-05 |
| Other-VS-Normal |
5.702100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83629999486834E-08 |
| Normal-vs-N1 |
4.84510000009486E-07 |
| N0-vs-N1 |
3.001000E-01 |
|
|
